# Official Journal C 250/9 Oc

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 250 |
| | |
| English edition | Information and Notices | Volume 479 October 2004 |

ISSN 1725-2423

Official Journal

of the European Union

C 250

English edition

Information and Notices

Volume 479 October 2004

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2004/C 250/1 | Euro exchange rates | 1 |
| 2004/C 250/2 | Prior notification of a concentration (Case COMP/M.3586 — Ripplewood/Honsel) — Candidate case for simplified procedure (
  1
  ) | 2 |
| 2004/C 250/3 | Prior notification of a concentration (Case COMP/M.3563 — CVC/BASF Printing Inks) — Candidate case for simplified procedure (
  1
  ) | 3 |
| 2004/C 250/4 | Prior notification of a concentration (Case COMP/M.3564 — CVC/ANI Printing Inks) (
  1
  ) | 4 |
| 2004/C 250/5 | Prior notification of a concentration (Case COMP/M.3275 — SHELL ESPAÑA/CEPSA/SIS) (
  1
  ) | 5 |
| 2004/C 250/6 | State aid — The Netherlands — Aid C 43/03 — Operating aid in favour of AVR for dealing with hazardous waste — Invitation to submit comments pursuant to Article 88(2) of the EC Treaty (
  1
  ) | 6 |
| 2004/C 250/7 | Amended list of experts appointed as members of the Scientific Committees | 8 |

Notice No

Contents

page

I   Information

Commission

2004/C 250/1

Euro exchange rates

1

2004/C 250/2

Prior notification of a concentration (Case COMP/M.3586 — Ripplewood/Honsel) — Candidate case for simplified procedure (
  1
  )

1

2

2004/C 250/3

Prior notification of a concentration (Case COMP/M.3563 — CVC/BASF Printing Inks) — Candidate case for simplified procedure (
  1
  )

1

3

2004/C 250/4

Prior notification of a concentration (Case COMP/M.3564 — CVC/ANI Printing Inks) (
  1
  )

1

4

2004/C 250/5

Prior notification of a concentration (Case COMP/M.3275 — SHELL ESPAÑA/CEPSA/SIS) (
  1
  )

1

5

2004/C 250/6

State aid — The Netherlands — Aid C 43/03 — Operating aid in favour of AVR for dealing with hazardous waste — Invitation to submit comments pursuant to Article 88(2) of the EC Treaty (
  1
  )

1

6

2004/C 250/7

Amended list of experts appointed as members of the Scientific Committees

8

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

I Information

Commission

| 9.10.2004 | EN | Official Journal of the European Union | C 250/1 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/1

---

Euro exchange rates (1)

8 October 2004

(2004/C 250/01)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2315 |
| JPY | Japanese yen | 136,05 |
| DKK | Danish krone | 7,4399 |
| GBP | Pound sterling | 0,6891 |
| SEK | Swedish krona | 9,068 |
| CHF | Swiss franc | 1,5529 |
| ISK | Iceland króna | 87,48 |
| NOK | Norwegian krone | 8,3 |
| BGN | Bulgarian lev | 1,9559 |
| CYP | Cyprus pound | 0,576 |
| CZK | Czech koruna | 31,36 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 246,18 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6649 |
| MTL | Maltese lira | 0,4289 |
| PLN | Polish zloty | 4,331 |
| ROL | Romanian leu | 41 050 |
| SIT | Slovenian tolar | 239,92 |
| SKK | Slovak koruna | 40,025 |
| TRL | Turkish lira | 1 845 500 |
| AUD | Australian dollar | 1,6944 |
| CAD | Canadian dollar | 1,5475 |
| HKD | Hong Kong dollar | 9,5937 |
| NZD | New Zealand dollar | 1,8193 |
| SGD | Singapore dollar | 2,0769 |
| KRW | South Korean won | 1 413,76 |
| ZAR | South African rand | 8,1603 |

Currency

Exchange rate

USD

US dollar

1,2315

JPY

Japanese yen

136,05

DKK

Danish krone

7,4399

GBP

Pound sterling

0,6891

SEK

Swedish krona

9,068

CHF

Swiss franc

1,5529

ISK

Iceland króna

87,48

NOK

Norwegian krone

8,3

BGN

Bulgarian lev

1,9559

CYP

Cyprus pound

0,576

CZK

Czech koruna

31,36

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

246,18

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6649

MTL

Maltese lira

0,4289

PLN

Polish zloty

4,331

ROL

Romanian leu

41 050

SIT

Slovenian tolar

239,92

SKK

Slovak koruna

40,025

TRL

Turkish lira

1 845 500

AUD

Australian dollar

1,6944

CAD

Canadian dollar

1,5475

HKD

Hong Kong dollar

9,5937

NZD

New Zealand dollar

1,8193

SGD

Singapore dollar

2,0769

KRW

South Korean won

1 413,76

ZAR

South African rand

8,1603

---

(1)

Source: reference exchange rate published by the ECB.

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/2 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/2

---

Prior notification of a concentration

(Case COMP/M.3586 — Ripplewood/Honsel)

Candidate case for simplified procedure

(2004/C 250/02)

(Text with EEA relevance)

| 1. | On 30 September 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Ripplewood Investments L.L.C. (‘Ripplewood’, USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking The Honsel Group (‘Honsel’, Luxemburg) by way of purchase of shares. |
| --- | --- |

1.

On 30 September 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Ripplewood Investments L.L.C. (‘Ripplewood’, USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking The Honsel Group (‘Honsel’, Luxemburg) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Ripplewood: private equity firm, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Ripplewood: private equity firm,

| — | for Honsel: light-metal (aluminium and magnesium) processing of parts and components for the automobile and non-automobile industry. |
| --- | --- |

—

for Honsel: light-metal (aluminium and magnesium) processing of parts and components for the automobile and non-automobile industry.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3586 — Ripplewood/Honsel, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3586 — Ripplewood/Honsel, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  Available on DG COMP website:

http://europa.eu.int/comm/competition/mergers/legislation/consultation/simplified_tru.pdf.

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/3 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/3

---

Prior notification of a concentration

(Case COMP/M.3563 — CVC/BASF Printing Inks)

Candidate case for simplified procedure

(2004/C 250/03)

(Text with EEA relevance)

| 1. | On 1 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Switzerland GmbH (‘CVC’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking BASF Drucksysteme GmbH and certain additional BASF AG assets in the field of pigments (‘BASF Inks’, Germany) by way of acquisition of shares and assets. |
| --- | --- |

1.

On 1 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Switzerland GmbH (‘CVC’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking BASF Drucksysteme GmbH and certain additional BASF AG assets in the field of pigments (‘BASF Inks’, Germany) by way of acquisition of shares and assets.

| 2. | The business activities of the undertakings concerned are:






  — | for CVC: financial investments in various industries, including chemicals, automotive, utilities, manufacturing, retailing and distribution, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CVC: financial investments in various industries, including chemicals, automotive, utilities, manufacturing, retailing and distribution,

| — | for BASF Inks: production of printing inks for publication and packaging applications, production of pigments for printing inks and the manufacture of printing plates. |
| --- | --- |

—

for BASF Inks: production of printing inks for publication and packaging applications, production of pigments for printing inks and the manufacture of printing plates.

| 3. | On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EEC) No 4064/89 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EEC) No 4064/89 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3563 — CVC/BASF Printing Inks, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3563 — CVC/BASF Printing Inks, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  Available on DG COMP website:

http://europa.eu.int/comm/competition/mergers/legislation/consultation/simplified_tru.pdf.

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/4 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/4

---

Prior notification of a concentration

(Case COMP/M.3564 — CVC/ANI Printing Inks)

(2004/C 250/04)

(Text with EEA relevance)

| 1. | On 1 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Switzerland GmbH (‘CVC’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking ANI Printing Inks B.V. (‘ANI’, the Netherlands) by acquisition of assets. |
| --- | --- |

1.

On 1 October 2004, the Commission received a notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Switzerland GmbH (‘CVC’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking ANI Printing Inks B.V. (‘ANI’, the Netherlands) by acquisition of assets.

| 2. | The business activities of the undertakings concerned are:






  — | for CVC: financial investments in various industries, including chemicals, automotive, utilities, manufacturing, retailing and distribution, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CVC: financial investments in various industries, including chemicals, automotive, utilities, manufacturing, retailing and distribution,

| — | for ANI: production of printing inks for publication and packaging applications. |
| --- | --- |

—

for ANI: production of printing inks for publication and packaging applications.

| 3. | On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3564 — CVC/ANI Printing Inks, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3564 — CVC/ANI Printing Inks, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/5 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/5

---

Prior notification of a concentration

(Case COMP/M.3275 — SHELL ESPAÑA/CEPSA/SIS)

(2004/C 250/05)

(Text with EEA relevance)

| 1. | On 1 October 2004 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Shell España, S.A. (‘Shell España’, Spain), belonging to the Royal Dutch/Shell group, and Compañía Española de Petróleos, S.A. (‘Cepsa’, Spain) acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of the newly created company constituting a joint venture Spanish Into-plane Services, S.L. (‘SIS’, Spain) by way of purchase of shares. |
| --- | --- |

1.

On 1 October 2004 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Shell España, S.A. (‘Shell España’, Spain), belonging to the Royal Dutch/Shell group, and Compañía Española de Petróleos, S.A. (‘Cepsa’, Spain) acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of the newly created company constituting a joint venture Spanish Into-plane Services, S.L. (‘SIS’, Spain) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Shell España: production, distribution and sale of motor, aviation, marine and domestic fuels, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Shell España: production, distribution and sale of motor, aviation, marine and domestic fuels,

| — | for Cepsa: exploration, production, marketing and transportation of crude oil, natural gas and related products, |
| --- | --- |

—

for Cepsa: exploration, production, marketing and transportation of crude oil, natural gas and related products,

| — | for SIS: supply of fuel into-plane services at airports on the Spanish mainland and the Balearic Islands. |
| --- | --- |

—

for SIS: supply of fuel into-plane services at airports on the Spanish mainland and the Balearic Islands.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3275 — SHELL ESPAÑA/CEPSA/SIS, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No +32/2/2964301 or 2967244) or by post, under reference number COMP/M.3275 — SHELL ESPAÑA/CEPSA/SIS, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/6 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/6

---

STATE AID — THE NETHERLANDS

Aid C 43/03 — Operating aid in favour of AVR for dealing with hazardous waste

Invitation to submit comments pursuant to Article 88(2) of the EC Treaty

(2004/C 250/06)

(Text with EEA relevance)

By means of the letter dated 14 July 2004 reproduced in the authentic language following this summary, the Commission notified the Netherlands of its decision to extend the procedure laid down in Article 88(2) of the EC Treaty concerning the abovementioned measure which it initiated by its decision of 24 June 2003 (1).

Interested parties may submit their comments on the measure in respect of which the Commission is extending the procedure within one month of the date of publication of this summary and the following letter, to:

| European Commission |
| --- |
| Directorate-General for Competition |
| State Aid Greffe |
| B-1049 Brussels |
| Fax (32-2) 296 12 42 |

European Commission

Directorate-General for Competition

State Aid Greffe

B-1049 Brussels

Fax (32-2) 296 12 42

These comments will be communicated to the Netherlands. Confidential treatment of the identity of the interested party submitting the comments may be requested in writing, stating the reasons for the request.

SUMMARY

On 24 June 2003 the Commission initiated the procedure of Article 88(2) of the Treaty with respect to operating aid to AVR Nutsbedrijf Gevaarlijk Afval BV for operating a special landfill site and rotating drum furnaces installations for particular categories of highly hazardous waste.

For details, see the publication in Official Journal C 196 of 20 August 2003, p. 5.

Following this decision, the Dutch authorities informed the Commission that due to difficult market conditions the pre-calculated deficit for 2004, which equals the aid for this year, amounts to EUR 8,9 million. This is substantially higher than foreseen earlier.

In addition, it has been decided to close one of the two rotating drum furnaces.

In accordance with the aid covenant, the State will compensate AVR for the remaining book value of the not-yet depreciated investments that have been done during the duration of the agreement. This will amount to EUR 8,7 million. The relevant clause in the aid covenant applies as well in case of untimely closure of the other furnace and/or the C2 landfill site. For the remaining operating period, transparency as regards the tariffs for different categories of waste has been increased.

The Commission's preliminary assessment of the higher operating aid and the compensation for the cost of untimely closure of furnaces and/or the C2 landfill site constitute State aid in the meaning of Article 87(1) of the Treaty. For the same reasons as expressed in its decision of 24 June 2003, the Commission doubts whether this aid can be found compatible with the common market.

TEXT OF LETTER

‘De Commissie wenst Nederland ervan in kennis te stellen dat zij, na onderzoek van de door uw autoriteiten verstrekte informatie over de bovengenoemde maatregel, heeft besloten tot uitbreiding van de procedure van artikel 88, lid 2, van het EG-Verdrag die zij met haar beschikking van 24 juni 2003 (2).

De procedure betreft operationele steun ten gunste van AVR Nutsbedrijf Gevaarlijk Afval BV voor het runnen van een speciale deponie en draaitrommelovens voor bijzondere categorieën van zeer gevaarlijk afval.

Na de beschikking hebben de Nederlandse autoriteiten aanvullende informatie ten aanzien van de maatregel gezonden bij brieven van 25.9.2003, 18.12.2003, 23.1.2004, 25.2.2004 en 23.4.2004. De Commissie is op de hoogte gesteld dat wegens moeilijke marktomstandigheden het voorcalculatorische tekort voor 2004, hetgeen gelijk is aan de steun voor dit jaar, 8,9 miljoen EUR bedroeg. Dit is aanzienlijk hoger dan aanvankelijk voorzien. Daarnaast is besloten om een van de twee draaitrommelovens te sluiten. Op grond van het convenant zal de staat AVR compenseren voor de resterende boekwaarde van nog niet afgeschreven investeringen die AVR tijdens de duur van de overeenkomst heeft gedaan met instemming van de staat. Deze compensatie zal 8,7 miljoen EUR bedragen. Deze clausule is ook van toepassing in geval van voortijdige sluiting van de resterende draaitrommeloven en/of de C2-deponie.

Met betrekking tot het runnen van de ovens (tot sluiting) hebben de Nederlandse autoriteiten aangegeven dat de transparantie vergroot is. AVR zal dezelfde tarieven hanteren voor alle categorieën van steun die het opneemt, niet slechts het gevaarlijke afval, maar ook het afval dat gebruikt wordt voor het bijstoken van de ovens.

In haar eerste beoordeling in de beschikking van 24 juni 2003 licht de Commissie toe waarom de compensatie voor de voorcalculatorische tekorten staatssteun vormt in de zin van artikel 87, lid 1, van het Verdrag. Haar eerste beoordeling in deze beschikking is dat de compensatie die gerelateerd is aan het sluiten van de ovens en/of het C2-depot eveneens staatssteun vormt, daar deze onlosmakelijk verbonden is met hetzelfde contract dat ziet op de verwerking van gevaarlijk afval. Om dezelfde redenen als genoemd in haar beschikking van 24 juni 2003 twijfelt de Commissie of de hogere operationele steun voor 2004 en de compensatie(s) verenigbaar zijn met de gemeenschappelijke markt.

Gelet op de bovenstaande overwegingen maant de Commissie Nederland aan, haar binnen een maand na de datum van ontvangst van dit schrijven, alle bescheiden, inlichtingen en gegevens te verstrekken die noodzakelijk zijn om de verenigbaarheid van de steunmaatregel te beoordelen. Bij uitblijven van een reactie zal de Commissie een beslissing nemen aan de hand van de gegevens waarover zij beschikt. Zij verzoekt uw autoriteiten onverwijld een afschrift van deze brief aan de potentiële begunstigde van de steunmaatregel te doen toekomen.

De Commissie wijst Nederland op de schorsende werking van artikel 88, lid 3, van het EG-Verdrag. Zij verwijst naar artikel 14 van Verordening (EG) nr. 659/1999, volgens hetwelk elke onrechtmatige steun van de begunstigde kan worden teruggevorderd.

Voorts deelt de Commissie Nederland mee, dat zij de belanghebbenden door de bekendmaking van dit schrijven en van een samenvatting ervan in het Publicatieblad van de Europese Unie in kennis zal stellen. Tevens zal zij de belanghebbenden in de lidstaten van de EVA die partij zijn bij de EER-Overeenkomst door de bekendmaking van een mededeling in het EER-Supplement van het Publicatieblad in kennis stellen, alsmede de Toezichthoudende Autoriteit van de EVA door haar een afschrift van dit schrijven toe te zenden. Alle bovengenoemde belanghebbenden zal worden verzocht hun opmerkingen te maken binnen een maand vanaf de datum van deze bekendmaking.’.

---

(1)  OJ C 196, 20.8.2003, p. 5.

1

(2)  PB C 196 van 20.8.2003, blz. 5.

2

---

| 9.10.2004 | EN | Official Journal of the European Union | C 250/8 |
| --- | --- | --- | --- |

9.10.2004

EN

Official Journal of the European Union

C 250/8

---

AMENDED LIST OF EXPERTS APPOINTED AS MEMBERS OF THE SCIENTIFIC COMMITTEES

(2004/C 250/07)

Amended list in alphabetical order of the scientists appointed by the Commission as members of the Scientific Committees established by Commission Decision 2004/210/EC of 3 March 2004. This list replaces the lists published in the
  Official Journal of the European Union C 188 of 23 July 2004.

Scientific Committee on Consumer Products

| Dr Claire Chambers | Consultant Toxicologist, Chambers Toxicological Consulting. Research associate at the University of Dublin, Ireland. |
| --- | --- |
| Prof. Gisela Degen | Head of Biochemical-Toxicological Laboratory, Institut für Arbeitsphysiologie, University of Dortmund, Germany. |
| Prof. Ruta Dubakiene | Head of Allergy Centre, Vilnius University Antakalnis Clinical Hospital, Lithuania. |
| Prof. Corrado Galli | Director of the Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche, Università degli Studi di Milano, Italy. |
| Dr Ramon Grimalt | Assistant Professor dermatologist at Hospital Clinic of Barcelona, University of Barcelona, Spain. |
| Dr Bozena Jazwiec-Kanyion | Environmental scientist at the Institute of Occupational Medicine and Environmental Health, Poland. |
| Prof. Em. Vassilios Kapoulas | Emeritus Professor of Biochemistry, University of Ioannina, Greece. |
| Prof. Jean Krutmann | Director, Institut für Umweltmedizinische Forschung (IUF), Heinrich-Heine-University, Düsseldorf, Germany. |
| Prof. Carola Lidén | Head of Department of Occupational and Environmental Health, Stockholm Centre for Public Health, Sweden. |
| Prof. Em. Nicola Loprieno | Professor of Genetics, University of Pisa, Italy. |
| Prof. Jean-Paul Marty | Professor of Pharmacology, Laboratory of Dermopharmacology and Cosmetology, Faculty of Pharmacy, University of Paris South, France. |
| Prof. Thomas Platzek | Professor, Dr Rer. Nat., Bundesinstitut für Risikobewertung, Germany. |
| Dr Suresh Chandra Rastogi | Senior Research Scientist, Department of Environmental Chemistry and Microbiology, National Environmental Institute, Denmark. |
| Prof. Jean Revuz | Chef de service, Service universitaire de Dermatologie, Hôpital Henri Mondor, France. |
| Prof. Vera Maria Rogiers | Head of Department, Department of Toxicology, Dermato-Cosmetology and Pharmacognosy, Vrije Universiteit Brussel (VUB), Belgium. |
| Prof. Tore Sanner | Head of Department of Environmental and Occupational Cancer, The Norwegian Radium Hospital Institute for Cancer Research, Norway. |
| Prof. Günter Speit | Professor for Human Genetics, Department of Human Genetics, University Clinic Ulm, Germany. |
| Dr Jacqueline van Engelen | Centre for Substances and Integrated Risk Assessment, Senior scientist, National Institute for Public Health and the Environment, (RIVM), Netherlands. |
| Dr Ian White | Consultant Dermatologist, St John's Institute of Dermatology, St Thomas' Hospital, United Kingdom. |

Dr Claire Chambers

Consultant Toxicologist, Chambers Toxicological Consulting. Research associate at the University of Dublin, Ireland.

Prof. Gisela Degen

Head of Biochemical-Toxicological Laboratory, Institut für Arbeitsphysiologie, University of Dortmund, Germany.

Prof. Ruta Dubakiene

Head of Allergy Centre, Vilnius University Antakalnis Clinical Hospital, Lithuania.

Prof. Corrado Galli

Director of the Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche, Università degli Studi di Milano, Italy.

Dr Ramon Grimalt

Assistant Professor dermatologist at Hospital Clinic of Barcelona, University of Barcelona, Spain.

Dr Bozena Jazwiec-Kanyion

Environmental scientist at the Institute of Occupational Medicine and Environmental Health, Poland.

Prof. Em. Vassilios Kapoulas

Emeritus Professor of Biochemistry, University of Ioannina, Greece.

Prof. Jean Krutmann

Director, Institut für Umweltmedizinische Forschung (IUF), Heinrich-Heine-University, Düsseldorf, Germany.

Prof. Carola Lidén

Head of Department of Occupational and Environmental Health, Stockholm Centre for Public Health, Sweden.

Prof. Em. Nicola Loprieno

Professor of Genetics, University of Pisa, Italy.

Prof. Jean-Paul Marty

Professor of Pharmacology, Laboratory of Dermopharmacology and Cosmetology, Faculty of Pharmacy, University of Paris South, France.

Prof. Thomas Platzek

Professor, Dr Rer. Nat., Bundesinstitut für Risikobewertung, Germany.

Dr Suresh Chandra Rastogi

Senior Research Scientist, Department of Environmental Chemistry and Microbiology, National Environmental Institute, Denmark.

Prof. Jean Revuz

Chef de service, Service universitaire de Dermatologie, Hôpital Henri Mondor, France.

Prof. Vera Maria Rogiers

Head of Department, Department of Toxicology, Dermato-Cosmetology and Pharmacognosy, Vrije Universiteit Brussel (VUB), Belgium.

Prof. Tore Sanner

Head of Department of Environmental and Occupational Cancer, The Norwegian Radium Hospital Institute for Cancer Research, Norway.

Prof. Günter Speit

Professor for Human Genetics, Department of Human Genetics, University Clinic Ulm, Germany.

Dr Jacqueline van Engelen

Centre for Substances and Integrated Risk Assessment, Senior scientist, National Institute for Public Health and the Environment, (RIVM), Netherlands.

Dr Ian White

Consultant Dermatologist, St John's Institute of Dermatology, St Thomas' Hospital, United Kingdom.

Scientific Committee on Health and Environmental Risks

| Prof. Herman Autrup | Professor of Environmental Medicine, Department of Environmental and Occupational Medicine, University of Arhus, Denmark. |
| --- | --- |
| Prof. Peter Calow | Guest Professor at the Department of Life Sciences and Chemistry, Roskilde University, Denmark. |
| Prof. Dr Wolfgang Dekant | Professor at the Institut für Toxikologie Universität Würzburg, Germany. |
| Prof. Em. Helmut Greim | Professor of Toxicology at the Institute of Toxicology and Environmental Hygiene, Technical University of Munich, Germany. |
| Prof. Hanke Wojciech | Head of Environmental Reproductive Hazard Unit, Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Poland. |
| Prof. Dr Colin Janssen | Professor of Ecotoxicology, Ghent University, Belgium. |
| Prof. Bo Oscar Jansson | Professor at the Institute of Applied Environmental Research, Stockholm University, Sweden. |
| Dr Hannu Komulainen | Head of Laboratory of Toxicology, Division of Environmental Health, National Public Health Institute, Finland. |
| Dr Ole Ladefoged | Senior Scientist Danish Food and Veterinary Research, Institute of Food Safety and Nutrition, Denmark. |
| Dr Inge Mangelsdorf | Head of Department of Chemical Risk Assessment, Fraunhofer Institute for Toxicology and Experimental Medicine, Germany. |
| Prof. Marco Nuti | Professor, Dipartimento di Chimica e Biotecnologie Agrarie, Pisa University, Italy. |
| Prof. Jerzy Sokal | Director of Occupational Medecine and Environmental Health Institute, Poland. |
| Prof. Anne Steenhout | Professor of Ecotoxicology, Institute for Environmental Management and Physical Planning (GEEPSIH), Université Libre de Bruxelles, Belgium. |
| Dr Jose Tarazona | Director of Department of the Environment INIA, Spanish National Institute For Agriculture and Food Research and Technology, Spain. |
| Dr Emanuela Testai | Senior Scientist, Environment and Primary Prevention Mechanisms of Toxicity Unit, Instituto Superiore di Sanità, Italy. |
| Prof. Marco Vighi | Professor of Ecology and Applied Ecology, Department of Environmental Sciences, University of Milano Bicocca, Italy. |
| Dr Matti Viluksela | Senior researcher on Toxicology, Environmental Health Department, National Public Health Institute, Finland. |
| Prof. Joseph Vos | Professor of Toxicological Pathology Laboratory for Pathology and Immunobiology, National Institute for Public Health and the Environment (RIVM), Netherlands. |

Prof. Herman Autrup

Professor of Environmental Medicine, Department of Environmental and Occupational Medicine, University of Arhus, Denmark.

Prof. Peter Calow

Guest Professor at the Department of Life Sciences and Chemistry, Roskilde University, Denmark.

Prof. Dr Wolfgang Dekant

Professor at the Institut für Toxikologie Universität Würzburg, Germany.

Prof. Em. Helmut Greim

Professor of Toxicology at the Institute of Toxicology and Environmental Hygiene, Technical University of Munich, Germany.

Prof. Hanke Wojciech

Head of Environmental Reproductive Hazard Unit, Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Poland.

Prof. Dr Colin Janssen

Professor of Ecotoxicology, Ghent University, Belgium.

Prof. Bo Oscar Jansson

Professor at the Institute of Applied Environmental Research, Stockholm University, Sweden.

Dr Hannu Komulainen

Head of Laboratory of Toxicology, Division of Environmental Health, National Public Health Institute, Finland.

Dr Ole Ladefoged

Senior Scientist Danish Food and Veterinary Research, Institute of Food Safety and Nutrition, Denmark.

Dr Inge Mangelsdorf

Head of Department of Chemical Risk Assessment, Fraunhofer Institute for Toxicology and Experimental Medicine, Germany.

Prof. Marco Nuti

Professor, Dipartimento di Chimica e Biotecnologie Agrarie, Pisa University, Italy.

Prof. Jerzy Sokal

Director of Occupational Medecine and Environmental Health Institute, Poland.

Prof. Anne Steenhout

Professor of Ecotoxicology, Institute for Environmental Management and Physical Planning (GEEPSIH), Université Libre de Bruxelles, Belgium.

Dr Jose Tarazona

Director of Department of the Environment INIA, Spanish National Institute For Agriculture and Food Research and Technology, Spain.

Dr Emanuela Testai

Senior Scientist, Environment and Primary Prevention Mechanisms of Toxicity Unit, Instituto Superiore di Sanità, Italy.

Prof. Marco Vighi

Professor of Ecology and Applied Ecology, Department of Environmental Sciences, University of Milano Bicocca, Italy.

Dr Matti Viluksela

Senior researcher on Toxicology, Environmental Health Department, National Public Health Institute, Finland.

Prof. Joseph Vos

Professor of Toxicological Pathology Laboratory for Pathology and Immunobiology, National Institute for Public Health and the Environment (RIVM), Netherlands.

Scientific Committee on Emerging and Newly Identified Health Risks

| Prof. Anders Ahlbom | Professor and Head of Division of Epidemiology, Institute of Environmental Medicine. Director of Division of Epidemiology, Stockholm County Council, Karolinska Institutet, Sweden. |
| --- | --- |
| Prof. James Bridges | Professor of Toxicology and Environmental Health, United Kingdom. |
| Dr Wilhelmus De Jong | Toxicological Pathologist Laboratory for Toxicology Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Netherlands. |
| Dr Donato Greco | Director of National Centre for Epidemiology, Surveillance and Health Promotion, Instituto Superiore di Sanità, Italy. |
| Prof. Dr. Jana Hajslová | Head of the Laboratory Contaminants and Toxicants, Institute of Chemical Technology, Czech Republic. |
| Prof. Philippe Hartemann | Professeur de Santé Publique, Département Environnement et Santé Publique, Faculté de Médecine, Université de Nancy, France. |
| Dr Thomas Jung | Research group leader, Laboratory of Micro- and Nanostructure, Paul Scherrer Institut, Switzerland. |
| Prof. Mats-Olof Mattsson | Professor in Biology, Department of Natural Sciences, Orebro University, Sweden. |
| Dr Jean-Marie Pagès | Directeur de Recherche, Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine, Université de Marseille, France. |
| Prof. Konrad Rydzynski | Director General Nofer Institute of Occupational Medicine, Poland. |
| Dr Dorothea Stahl | Assistant Medical Director, Institute for Transfusion Medicine and Transplantation Immunology, University of Muenster, Germany. |
| Dr Mogens Thomsen | Research Director, Institut National de la Santé et de la Recherche Médicale (INSERM), Rangeuil, France. |
| Prof. David Williams | Director Centre for Tissue Engineering, Department of Clinical Engineering, University of Liverpool, United Kingdom. |

Prof. Anders Ahlbom

Professor and Head of Division of Epidemiology, Institute of Environmental Medicine. Director of Division of Epidemiology, Stockholm County Council, Karolinska Institutet, Sweden.

Prof. James Bridges

Professor of Toxicology and Environmental Health, United Kingdom.

Dr Wilhelmus De Jong

Toxicological Pathologist Laboratory for Toxicology Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Netherlands.

Dr Donato Greco

Director of National Centre for Epidemiology, Surveillance and Health Promotion, Instituto Superiore di Sanità, Italy.

Prof. Dr. Jana Hajslová

Head of the Laboratory Contaminants and Toxicants, Institute of Chemical Technology, Czech Republic.

Prof. Philippe Hartemann

Professeur de Santé Publique, Département Environnement et Santé Publique, Faculté de Médecine, Université de Nancy, France.

Dr Thomas Jung

Research group leader, Laboratory of Micro- and Nanostructure, Paul Scherrer Institut, Switzerland.

Prof. Mats-Olof Mattsson

Professor in Biology, Department of Natural Sciences, Orebro University, Sweden.

Dr Jean-Marie Pagès

Directeur de Recherche, Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine, Université de Marseille, France.

Prof. Konrad Rydzynski

Director General Nofer Institute of Occupational Medicine, Poland.

Dr Dorothea Stahl

Assistant Medical Director, Institute for Transfusion Medicine and Transplantation Immunology, University of Muenster, Germany.

Dr Mogens Thomsen

Research Director, Institut National de la Santé et de la Recherche Médicale (INSERM), Rangeuil, France.

Prof. David Williams

Director Centre for Tissue Engineering, Department of Clinical Engineering, University of Liverpool, United Kingdom.

Reserve list of experts

List in alphabetical order of the scientists constituting the reserve list of experts as set out in Article 4 of Commission Decision 2004/210/EC of 3 March 2004. This list replaces the lists published in the
  Official Journal of the European Union C 188 of 23 July 2004.

| Dr Andrew Bailey | Manager, Viral Safety Baxter AG, Austria. |
| --- | --- |
| Prof. Alfred Bernard | Research Director of National Fund for Scientific Research (FNRS), Faculty of Medicine, Catholic University of Louvain, Belgium. |
| Prof. Ronny Blust | Professor of Environmental Physiology and Toxicology, Biology Department, University of Antwerp, Belgium. |
| Anders Sverre Boman | Dermatoxicologist, Stockholm centre for Public Health, Stockholm County Council, Sweden. |
| Dr Paul George Brantom | Manager, Brantom Risk Assessment, United Kingdom. |
| Prof. David Briggs | Professor of of Environmental and Health Sciences, Department of Epidemiology and Public Health, Imperial College London, United Kingdom. |
| Dr Samuele Burastero | Department of Allergology, San Raffaele Scientific Institute, Milan, Italy. |
| Prof. Giorgio Cantelli Forti | Head of Toxicololgy Unit, Dean of the Faculty of Pharmacy, Department of Pharmacology, University of Bologna, Italy. |
| Dr María Argelia Castaño | Head of Laboratory on Alternative methods in Ecotoxicology, Ministry of Science and Technology CISA-INIA, Spain. |
| Dr Leonardo Celleno | Dermatologist, Università Cattolica del sacro Cuore Facolta di Medicina e Chirurgia di Roma, Italy. |
| Dr Sydney Christian | SD Christian Limited, United Kingdom. |
| Ing. Dr. Natale Consonni | Chemical engeneer, President and General Manager, Istituto Italiano Sicurezza dei Giocattoli, Italy. |
| Prof. Slawomir Czerczak | Professor, Nofer Institute of Occupational Medicine, Poland. |
| Prof. Kenneth Adrian Dawson | Chair of Physical Chemistry, University College Dublin, Ireland. |
| Dr Jean-François Doré | Research Director, Institut National de la Santé et de la Recherche Médicale (INSERM), France. |
| Prof. Brigitte Dreno | Professeur de Dermatologie, Université et CHU de Nantes, France. |
| Dr Tom Feijtel | Assistant Director, Corporate External Relations, Procter & Gamble Services Company, Belgium. |
| Dr Enzo Funari | Director of the Quality of the Aquatic Environment & Bathing Waters Section, Environmental and Related Primary Prevention Department, National Institute of Health, Italy. |
| Dr Antonietta Gatti | Universtiy Researcher and lecturer in Dental Materials and of Biomaterials and in Biomechanics, Università di Modena e Reggio Emilia, Italy. |
| Prof. Carlo Giunta | Professor of Biochemistry Department of Animal and Human Biology, University of Torino, Italy. |
| Dr Rémi Glomot | Consultant, expert toxicologist, France. |
| Prof. Charles L. Greenblatt | Professor of Parasitology, Hebrew University, Israel. |
| Prof. Dr Thomas Haertlé | Directeur de Recherches, Professeur des Sciences Biologiques, Institut National de la Recherche Agronomique (INRA), Nantes, France. |
| Dr Monka Herrchen | Head of Department, Department of Risk Assessment and Consulting, Fraunhofer-Institute Molecular Biology and Applied Ecology, Germany. |
| Prof. Rolf F. Hertel | Professor of Toxicology, Bundesinstitut für Risikobewertung, Germany. |
| Dr Walter Janssens | Teamleader, Division of Toxicology, Wetenschappelijk Instituut Volksgezondheid, Brussels, Belgium. |
| Prof. Bengt Järvholm | Head of Public Health and Clinical Medicine Department, Public Health and Clinical Medicine Department, Umea University, Sweden. |
| Dr Allan Astrup Jensen | Technical Vice President, Head Force Technology, Energy and Environment Department, Denmark. |
| Dr Dagmar Jirova | Czech Republic National Reference Centre for Cosmetics, National Institute of Public Health, Praha, Czech Republic. |
| Dr Bjorn Karlsson | Director Iceland Fire Authority, Iceland. |
| Prof. Fritz Kemper | Former Director of the Institute of Pharmacology and Toxicology, University of Münster, Germany. |
| Prof. Wlodzimierz Klonowski | Associate Professor, Biocybernetics and Biomedical Engineering Institute, Polish Academy of Sciences, Poland. |
| Prof. Claude René Lambré | Conseiller Scientifique du Directeur Général de la Santé — Risque Chimiques, Institut National de la Santé et de la Recherche Médical (INSERM), France. |
| Dr Jan Linders | Risk evaluator, expert in Pesticides, Centre for Substances and Risk Assessment, National Institute of Public Health and Environment (IRVM), Netherlands. |
| Dr Alberto Mantovani | Senior scientist, Dipartimento di Sanità Alimentare ed Animale, Istituto Superiore di Sanità, Italy. |
| Prof. Hans Marquardt | Director, Medical School Institute for Experimental and Clinical Toxicology, University of Hamburg, Germany. |
| Dr Gilberte Noëlle Marti-Mestres | Laboratoire de technique pharmaceutique industrielle, Faculté de pharmacie — Université de Montpellier, France. |
| Prof. Philippe, Raymond, Clément Masson | Directeur Scientifique et PDG Laboratoires EVIC, France. |
| Prof. Dieter Mayer | Pharmaceutical Technology Department, Johann Wolfgang Goethe University, Frankfurt, Germany. |
| Dr Henricus Miedema | Head of the Department Environment and Health, Organisation for applied Scientific Research (TNO), Netherlands. |
| Dr Maurizio Muraca | Head of Department of Medical and Surgical Sciences, Centre for Cell Therapy of Metabolic Disorders, Italy. |
| Prof. Anders Neil | Associated Professor, Division of Clinical Trials, Medical Products Agency, Sweden. |
| Prof. Benoît Nemery | Professor of Toxicology and Occupational Medicine, Department of Pneumology, Occupational, Environmental and Insurance Medicine, Catholic University of Louvain, Belgium. |
| Prof. Maud Monica Nordberg | Professor of Environmental Medicine, Environmental Medicine Institute, Karolinska Institute, Sweden. |
| Dr Claudius Nübling | Head of Molecular Pathology Section, Federal Agency for Sera and Vaccines Paul-Ehrlich-Institut, Germany. |
| Prof. Günter Oberdörster | Director UR-EPA, Department of Environmental Medicine — Medical Center, University of Rochester, United States. |
| Prof. Franz Oesch | Director of the Institute of Toxicology, University of Mainz, Germany. |
| Prof. Rodolfo Paoletti | Director, Department of Pharmacological Sciences, University of Milan, Italy. |
| Prof. Hans Persson | Professor, Department of Ecology and Environmental Research, Swedish University of Agricultural Sciences Ecology and Environmental Sciences, Sweden. |
| Dr Claudia Pölloth | Independent Toxicology Consultant, Germany. |
| Dr Elisabeth Robert-Gnansia | Directeur Scientifique, Intitut Europeen de Génomutations, France. |
| Prof. Eduardo Rodriguez-Farré | Research Professor of Physiology and Pharmacology, Consejo Superior de Investigaciones Cientificas (CSIC), Barcelona Institute of Biomedical Research (IIBB), Spain. |
| Dr Axel Schnuch | Universitätshautklinik Göttingen, Germany. |
| Prof. Fina Simeonova | Professor of Toxicology (retired), Bulgaria. |
| Prof Amadeu Soares | Head of Biology Department, Faculty of Biology, University of Aveiro, Portugal. |
| Prof. Walter Steurbaut | Professeur de Phytopharmacie, Département de Défense des Végétaux, Université de Gand, Belgium. |
| Prof. Dusan Suput | Professor of Pathophysilogy, Medical Faculty, University of Ljubljana, Slovenia. |
| Prof. Benedetto Terracini | Professor of Cancer Epidemiology (retired), Italy. |
| Prof. Antonella Tosti | Director Center of Allergology, Institute of Clinical Dermatology, University of Bologna, Italy. |
| Prof. Tatiana Varadinova | Associated Professor in Virology and Immunology, Faculty of Biology Laboratory of Virology, Sofia University, Bulgaria. |
| Dr Theodorus Vermeire | Head of Integration and Exposure Department, National Institute of Public Health and the Environment (RIVM), Netherlands. |
| Dr Martine Vigan | Head of Unit, Allergologie Dermatologie, Hôpital St Jacques, France. |
| Prof. Denis Zmirou | Directeur Scientifique, Agence Française de Sécurité Sanitaire Environnementale (AFSSE), France. |

Dr Andrew Bailey

Manager, Viral Safety Baxter AG, Austria.

Prof. Alfred Bernard

Research Director of National Fund for Scientific Research (FNRS), Faculty of Medicine, Catholic University of Louvain, Belgium.

Prof. Ronny Blust

Professor of Environmental Physiology and Toxicology, Biology Department, University of Antwerp, Belgium.

Anders Sverre Boman

Dermatoxicologist, Stockholm centre for Public Health, Stockholm County Council, Sweden.

Dr Paul George Brantom

Manager, Brantom Risk Assessment, United Kingdom.

Prof. David Briggs

Professor of of Environmental and Health Sciences, Department of Epidemiology and Public Health, Imperial College London, United Kingdom.

Dr Samuele Burastero

Department of Allergology, San Raffaele Scientific Institute, Milan, Italy.

Prof. Giorgio Cantelli Forti

Head of Toxicololgy Unit, Dean of the Faculty of Pharmacy, Department of Pharmacology, University of Bologna, Italy.

Dr María Argelia Castaño

Head of Laboratory on Alternative methods in Ecotoxicology, Ministry of Science and Technology CISA-INIA, Spain.

Dr Leonardo Celleno

Dermatologist, Università Cattolica del sacro Cuore Facolta di Medicina e Chirurgia di Roma, Italy.

Dr Sydney Christian

SD Christian Limited, United Kingdom.

Ing. Dr. Natale Consonni

Chemical engeneer, President and General Manager, Istituto Italiano Sicurezza dei Giocattoli, Italy.

Prof. Slawomir Czerczak

Professor, Nofer Institute of Occupational Medicine, Poland.

Prof. Kenneth Adrian Dawson

Chair of Physical Chemistry, University College Dublin, Ireland.

Dr Jean-François Doré

Research Director, Institut National de la Santé et de la Recherche Médicale (INSERM), France.

Prof. Brigitte Dreno

Professeur de Dermatologie, Université et CHU de Nantes, France.

Dr Tom Feijtel

Assistant Director, Corporate External Relations, Procter & Gamble Services Company, Belgium.

Dr Enzo Funari

Director of the Quality of the Aquatic Environment & Bathing Waters Section, Environmental and Related Primary Prevention Department, National Institute of Health, Italy.

Dr Antonietta Gatti

Universtiy Researcher and lecturer in Dental Materials and of Biomaterials and in Biomechanics, Università di Modena e Reggio Emilia, Italy.

Prof. Carlo Giunta

Professor of Biochemistry Department of Animal and Human Biology, University of Torino, Italy.

Dr Rémi Glomot

Consultant, expert toxicologist, France.

Prof. Charles L. Greenblatt

Professor of Parasitology, Hebrew University, Israel.

Prof. Dr Thomas Haertlé

Directeur de Recherches, Professeur des Sciences Biologiques, Institut National de la Recherche Agronomique (INRA), Nantes, France.

Dr Monka Herrchen

Head of Department, Department of Risk Assessment and Consulting, Fraunhofer-Institute Molecular Biology and Applied Ecology, Germany.

Prof. Rolf F. Hertel

Professor of Toxicology, Bundesinstitut für Risikobewertung, Germany.

Dr Walter Janssens

Teamleader, Division of Toxicology, Wetenschappelijk Instituut Volksgezondheid, Brussels, Belgium.

Prof. Bengt Järvholm

Head of Public Health and Clinical Medicine Department, Public Health and Clinical Medicine Department, Umea University, Sweden.

Dr Allan Astrup Jensen

Technical Vice President, Head Force Technology, Energy and Environment Department, Denmark.

Dr Dagmar Jirova

Czech Republic National Reference Centre for Cosmetics, National Institute of Public Health, Praha, Czech Republic.

Dr Bjorn Karlsson

Director Iceland Fire Authority, Iceland.

Prof. Fritz Kemper

Former Director of the Institute of Pharmacology and Toxicology, University of Münster, Germany.

Prof. Wlodzimierz Klonowski

Associate Professor, Biocybernetics and Biomedical Engineering Institute, Polish Academy of Sciences, Poland.

Prof. Claude René Lambré

Conseiller Scientifique du Directeur Général de la Santé — Risque Chimiques, Institut National de la Santé et de la Recherche Médical (INSERM), France.

Dr Jan Linders

Risk evaluator, expert in Pesticides, Centre for Substances and Risk Assessment, National Institute of Public Health and Environment (IRVM), Netherlands.

Dr Alberto Mantovani

Senior scientist, Dipartimento di Sanità Alimentare ed Animale, Istituto Superiore di Sanità, Italy.

Prof. Hans Marquardt

Director, Medical School Institute for Experimental and Clinical Toxicology, University of Hamburg, Germany.

Dr Gilberte Noëlle Marti-Mestres

Laboratoire de technique pharmaceutique industrielle, Faculté de pharmacie — Université de Montpellier, France.

Prof. Philippe, Raymond, Clément Masson

Directeur Scientifique et PDG Laboratoires EVIC, France.

Prof. Dieter Mayer

Pharmaceutical Technology Department, Johann Wolfgang Goethe University, Frankfurt, Germany.

Dr Henricus Miedema

Head of the Department Environment and Health, Organisation for applied Scientific Research (TNO), Netherlands.

Dr Maurizio Muraca

Head of Department of Medical and Surgical Sciences, Centre for Cell Therapy of Metabolic Disorders, Italy.

Prof. Anders Neil

Associated Professor, Division of Clinical Trials, Medical Products Agency, Sweden.

Prof. Benoît Nemery

Professor of Toxicology and Occupational Medicine, Department of Pneumology, Occupational, Environmental and Insurance Medicine, Catholic University of Louvain, Belgium.

Prof. Maud Monica Nordberg

Professor of Environmental Medicine, Environmental Medicine Institute, Karolinska Institute, Sweden.

Dr Claudius Nübling

Head of Molecular Pathology Section, Federal Agency for Sera and Vaccines Paul-Ehrlich-Institut, Germany.

Prof. Günter Oberdörster

Director UR-EPA, Department of Environmental Medicine — Medical Center, University of Rochester, United States.

Prof. Franz Oesch

Director of the Institute of Toxicology, University of Mainz, Germany.

Prof. Rodolfo Paoletti

Director, Department of Pharmacological Sciences, University of Milan, Italy.

Prof. Hans Persson

Professor, Department of Ecology and Environmental Research, Swedish University of Agricultural Sciences Ecology and Environmental Sciences, Sweden.

Dr Claudia Pölloth

Independent Toxicology Consultant, Germany.

Dr Elisabeth Robert-Gnansia

Directeur Scientifique, Intitut Europeen de Génomutations, France.

Prof. Eduardo Rodriguez-Farré

Research Professor of Physiology and Pharmacology, Consejo Superior de Investigaciones Cientificas (CSIC), Barcelona Institute of Biomedical Research (IIBB), Spain.

Dr Axel Schnuch

Universitätshautklinik Göttingen, Germany.

Prof. Fina Simeonova

Professor of Toxicology (retired), Bulgaria.

Prof Amadeu Soares

Head of Biology Department, Faculty of Biology, University of Aveiro, Portugal.

Prof. Walter Steurbaut

Professeur de Phytopharmacie, Département de Défense des Végétaux, Université de Gand, Belgium.

Prof. Dusan Suput

Professor of Pathophysilogy, Medical Faculty, University of Ljubljana, Slovenia.

Prof. Benedetto Terracini

Professor of Cancer Epidemiology (retired), Italy.

Prof. Antonella Tosti

Director Center of Allergology, Institute of Clinical Dermatology, University of Bologna, Italy.

Prof. Tatiana Varadinova

Associated Professor in Virology and Immunology, Faculty of Biology Laboratory of Virology, Sofia University, Bulgaria.

Dr Theodorus Vermeire

Head of Integration and Exposure Department, National Institute of Public Health and the Environment (RIVM), Netherlands.

Dr Martine Vigan

Head of Unit, Allergologie Dermatologie, Hôpital St Jacques, France.

Prof. Denis Zmirou

Directeur Scientifique, Agence Française de Sécurité Sanitaire Environnementale (AFSSE), France.

---